These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8831399)

  • 21. Influence of UDCG-115 on hemodynamics and myocardial energetics in patients with idiopathic dilated cardiomyopathy.
    Hasenfuss G; Holubarsch C; Heiss HW; Just H
    Am Heart J; 1989 Sep; 118(3):512-9. PubMed ID: 2773772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute cardiovascular effects of OPC-18790 in patients with congestive heart failure. Time- and dose-dependence analysis based on pressure-volume relations.
    Feldman MD; Pak PH; Wu CC; Haber HL; Heesch CM; Bergin JD; Powers ER; Cowart TD; Johnson W; Feldman AM; Kass DA
    Circulation; 1996 Feb; 93(3):474-83. PubMed ID: 8565164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential response to vesnarinone by cardiac fibroblasts isolated from normal and aortic regurgitant hearts.
    Ross JS; Goldfine SM; Herrold EM; Borer JS
    Am J Ther; 1998 Nov; 5(6):369-75. PubMed ID: 10099079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of acute hemodynamic response to dobutamine and intravenous MDL 17,043 (enoximone) in severe congestive heart failure secondary to ischemic cardiomyopathy or idiopathic dilated cardiomyopathy.
    Likoff MJ; Ulrich S; Hakki A; Iskandrian AS
    Am J Cardiol; 1986 Jun; 57(15):1328-34. PubMed ID: 2940855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of a new inotropic agent, OPC-8212, in patients with dilated cardiomyopathy and heart failure.
    Feldman AM; Becker LC; Llewellyn MP; Baughman KL
    Am Heart J; 1988 Sep; 116(3):771-7. PubMed ID: 3046278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Inotropic effect of novel cardiotonic agent, vesnarinone--tests on anaesthetized dogs].
    Han W; Wu Y; Zhang Z; Yang Z; Cai G
    Hua Xi Yi Ke Da Xue Xue Bao; 1996 Sep; 27(3):282-5. PubMed ID: 9389063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy.
    Quaife RA; Gilbert EM; Christian PE; Datz FL; Mealey PC; Volkman K; Olsen SL; Bristow MR
    Am J Cardiol; 1996 Oct; 78(7):779-84. PubMed ID: 8857482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sustained inotropic effects of a new cardiotonic agent. OPC-8212 in patients with chronic heart failure.
    Asanoi H; Sasayama S; Kameyama T; Ishizaka S; Iuchi K
    Clin Cardiol; 1989 Mar; 12(3):133-8. PubMed ID: 2647327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Enoximone, vasodilator and/or inotropic agent in congestive cardiac insufficiency? Hemodynamic and ventriculographic study of 20 cases].
    Durrieu C; Rochoux G; Coste P; Le Goff G; Besse P
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():43-50. PubMed ID: 2147834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics and pharmacodynamics of enantiomers of pimobendan in patients with dilated cardiomyopathy and congestive heart failure after single and repeated oral dosing.
    Chu KM; Shieh SM; Hu OY
    Clin Pharmacol Ther; 1995 Jun; 57(6):610-21. PubMed ID: 7781260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reassessment of digoxin and other low-dose positive inotropes in the treatment of chronic heart failure.
    Tauke J; Han D; Gheorghiade M
    Cardiovasc Drugs Ther; 1994 Oct; 8(5):761-8. PubMed ID: 7873474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of oral milrinone on end-systolic relations in patients with severe congestive heart failure.
    Miller WP; Ark CR; Wiederholt P
    Am J Cardiol; 1987 Oct; 60(10):842-6. PubMed ID: 3661398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update on digoxin and other oral positive inotropic agents for chronic heart failure.
    Reddy S; Benatar D; Gheorghiade M
    Curr Opin Cardiol; 1997 May; 12(3):233-41. PubMed ID: 9243080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of pimobendan (UD-CG 115 BS) on left ventricular inotropic state in conscious dogs and in patients with heart failure.
    Pouleur H; Hanet C; Schröder E; Col J; Van Mechelen H; Etienne J; Rousseau MF
    J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S18-22. PubMed ID: 2478787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The acute effect of a new positive inotropic agent (AR-L 115 BS) on cardiac hemodynamics and contractility in patients with severe chronic congestive heart failure.
    Hauf GF; Bubenheimer P; Roskamm H
    Arzneimittelforschung; 1981; 31(1a):253-6. PubMed ID: 7195235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of inotrope withdrawal on morbidity and mortality in patients with chronic heart failure: results of the vesnarinone trial withdrawal substudy. Vest Withdrawal Substudy Group.
    Soran O; Young JD; Holubkov R; Loftus S; Bourge R; Carson P; Jaski B; White BG; Feldman AM
    J Card Fail; 1999 Sep; 5(3):195-200; discussion 201-2. PubMed ID: 10496192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival in severe left ventricular failure treated with the new nonglycosidic, nonsympathomimetic oral inotropic agents.
    Simonton CA; Daly PA; Kereiakes D; Modin G; Chatterjee K
    Chest; 1987 Jul; 92(1):118-23. PubMed ID: 2954776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Review of a dose-dependent increase in mortality with vesnarinone among patients with severe heart failure.
    LeJemtel TH
    Curr Cardiol Rep; 1999 May; 1(1):31. PubMed ID: 10980817
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of pimobendan in addition to standard therapy for heart failure on prevention of readmission in elderly patients with severe chronic heart failure.
    Kawano H; Arakawa S; Satoh O; Matsumoto Y; Hayano M; Nakatomi D; Yamasa T; Maemura K
    Geriatr Gerontol Int; 2014 Jan; 14(1):109-14. PubMed ID: 23581555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group.
    Circulation; 1995 Jul; 92(2):212-8. PubMed ID: 7600653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.